trending Market Intelligence /marketintelligence/en/news-insights/trending/OLXW8YolHaBhsk1zem_6Hg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Roche's cobas Zika virus test gets US FDA approval

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Roche's cobas Zika virus test gets US FDA approval

Roche Holding AG secured the U.S. Food and Drug Administration's approval for the cobas Zika test.

Cobas is the first commercially available test for the detection of the Zika virus RNA in samples of human plasma intended for use in screening blood donations.

Roche deployed the cobas Zika test in April 2016 under the FDA's investigational new drug application protocol to screen blood donations collected in Puerto Rico.